GgoogleNL first seen 17 d ago, last 4 d ago, peak #1
Pharming Group posts profits and rising Q3 revenue
Original: pharming
Dutch biotech Pharming Group is in the news after reporting black figures and higher revenue in its third-quarter results. The company also presented positive study results for its drug leniolisib at a medical conference. Investors reacted with a rising share price, though analysts note the real test still lies ahead in the US regulatory process.
Why now: The company just reported quarterly results showing growth and profitability, moving the share price.
Evidence
- Pharming Q3-bedrijfswinst stijgt 89%, verfijnt omzetverwachting 2026 · Investing.com
- Zwarte cijfers voor Pharming · IEX.nl
- Pharming-aandeel stijgt na omzetgroei in Q3 · Investing.com
- Voor Pharming begint het zware werk pas na de FDA-zegen · De Belegger
- Pharming presenteert positieve studieresultaten met leniolisib tijdens congres · Headliner.nl
API: https://socialmediatrends-api.osmike.com/v1/trends/2248448